Prof. Dr. Alaattin YILDIZ

Deneyim

MEMORIAL ŞİŞLİ HASTANESİ

Nefroloji Uzmanı
2019 - Halen, İstanbul/Türkiye

VANDERBİLT UNIVERSİTY MEDICAL CENTER

Nefroloji Uzmanı Fellow
2001 - 2004, ABD

MASSACHUSETTS GENERAL HOSPITAL

Nefroloji Uzmanı
1995 - 1996, ABD

İSTANBUL ÜNİVERSİTESİ İSTANBUL TIP FAKÜLTESİ

Nefroloji Uzmanı
1992 - Halen, İstanbul/Türkiye

Eğitim

PROFESÖR

2003

DOÇENT

1997

İSTANBUL ÜNİVERSİTESİ İSTANBUL TIP FAKÜLTESİ

Nefroloji Yandal Uzmanlık Eğitimi
1992 - 1997 , İstanbul/Türkiye

İSTANBUL ÜNİVERSİTESİ İSTANBUL TIP FAKÜLTESİ

İç Hastalıkları Uzmanlık Eğitimi
1987 - 1992 , İstanbul/Türkiye

İSTANBUL ÜNİVERSİTESİ İSTANBUL TIP FAKÜLTESİ

Tıp Doktoru Eğitimi
1981 - 1987 , İstanbul/Türkiye

Bilimsel Yayınları

  • Böbrek nakli ile ilgili uluslararası 34 yayın
  • Kronik böbrek yetersizliği ile ilgili uluslararası 55 yayın
  • Transplantation, American Journal of Transplantation, Nephrology Dialysis Transplantation, Kidney International, American Journal of Kidney Diseases, Diabetic Medicine  

Dr. Alaattin Yıldız’ın Böbrek Nakli ile İlgili Uluslararası Yayınları

  •  Yildiz A, Sever MS, Demirel S, Akkaya V, Türk S, Türkmen A, Ecder T, Ark E.Improvement of uremic autonomic dysfunction after renal transplantation: a heartrate variability study. Nephron. 1998 Sep;80(1):57-60.
  • Yildiz A, Sever MS, Türkmen A, Ecder T, Beşişik F, Tabak L, Ece T, Kiliçarslan I, Ark E. Tuberculosis after renal transplantation: experience of one Turkish centre.Nephrol Dial Transplant. 1998 Jul;13(7):1872-5.
  • Yildiz A, Sever MS, Türkmen A, Ecder T, Türk S, Akkaya V, Ark E. Interaction between cyclosporine A and verapamil, felodipine, and isradipine. Nephron. 1999Jan;81(1):117-8.
  • Sever MS, Yildiz A, Eraksoy H, Badur S, Yüksel-Onel D, Görçin B, Türk S,Erkoç R. Immune response to Haemophilus influenzae type B vaccination in renaltransplant recipients with well-functioning allografts. Nephron. 1999;81(1):55-9.
  • Sayiner A, Ece T, Duman S, Yildiz A, Ozkahya M, Kiliçaslan Z, Tokat Y.Tuberculosis in renal transplant recipients. Transplantation. 1999;15;68(9):1268-71.
  • Yilmaz BA, Caliskan Y, Yilmaz A, Ozkok A, Bilge AK, Deniz G, Sariyar M, Yildiz A Cardiovascular-renal changes after kidney donation: one-year follow-up study.Transplantation. 2015 Apr;99(4):760-4.
  • Yildiz A, Erkoç R, Sever MS,Türkmen A, Ecder ST,Türk S, Kiliçarslan I, Ark E.The prognostic importance of severity and type of post-transplant proteinuria.Clin Transplant. 1999 Jun;13(3):241-4.
  • Yildiz A, Beşişik F, Akkaya V, Sever MS, Bozfakioğlu S, Yilmaz G, Ark E.Helicobacter pylori antibodies in hemodialysis patients and renal transplant recipients.Clin Transplant. 1999 Feb;13(1 Pt 1):13-6.
  • Ecder ST, Sever MS, Yildiz A, Türkmen A, Kayacan SM, Kiliçaslan I, Koçak T, Eldegez U. Kaposi's sarcoma after renal transplantation in Turkey. Clin Transplant. 1998 Oct;12(5):472-5.
  • Yildiz A, Cine N, Akkaya V, Sahin S, Ismailoğlu V, Türk S, Bozfakioğlu S, Sever MS. Comparison of the effects of enalapril and losartan on posttransplantation erythrocytosis in renal transplant recipients: prospective randomized study.Transplantation.2001;15;72(3):542-4.
  • Yildiz A, Akkaya V, Tükek T, Sahin S, Sever MS, Bozfakioğlu S, Korkut F.Increased QT dispersion in hemodialysis patients improve after renaltransplantation: a prospective-controlled study. Transplantation. 2001;15;72(9):1523-6.
  • Sever MS, Kazancioğlu R, Yildiz A, Türkmen A, Ecder T, Kayacan SM, Celik V,Sahin S, Aydin AE, Eldegez U, Ark E. Outcome of living unrelated (commercial) renal transplantation. Kidney Int. 2001;60(4):1477-83.
  • Türk S, Yildiz A, Tükek T, Akkaya V, Aras U, Türkmen A, Uras AR, Sever MS.The effect of fluvastatin of hyperlipidemia in renal transplant recipients: a prospective, placebo-controlled study. Int Urol Nephrol. 2001;32(4):713-6.
  • Yildiz A, Tütüncü Y, Yazici H, Akkaya V, Kayacan SM, Sever MS, Carin M, Karşidağ K. Association between hepatitis C virus infection and development of posttransplantation diabetes mellitus in renal transplant recipients.Transplantation. 2002;74(8):1109-13.
  • Yildiz A, Yazici H, Cine N, Akkaya V, Kayacan SM, Sever MS, Erginel-Unaltuna N.The effect of angiotensin converting enzyme gene polymorphism on chronic allograftdysfunction in living donor renal transplant recipients. Clin Transplant. 2002;16(3):173-9.Oflaz H, Pusuroglu H, Genchallac H, Demirel S, Bugra Z, Sever MS, Yildiz A.Endothelial function is more impaired in hemodialysis patients than renal transplant recipients. Clin Transplant. 2003 Dec;17(6):528-33.
  • Yildiz A, Yazici H, Cine N, Kazancioglu R, Akkaya V, Sever MS, Ark E, Erginel-Unaltuna N. Angiotensin converting enzyme gene polymorphism and development of post-transplant erythrocytosis. J Nephrol. 2003 May-Jun;16(3):399-403.
  • Kiyan E, Kilicaslan Z, Gurgan M, Tunaci A, Yildiz A. Clinical and radiographic features of pulmonary tuberculosis in non-AIDS immunocompromised patients.Int J Tuberc Lung Dis. 2003 Aug;7(8):764-70.
  • Kayacan SM, Yildiz A, Kazancioglu R, Sahin S, Sever MS, Ark E. The changes in serum leptin, body fat mass and insulin resistance after renal transplantation.Clin Transplant. 2003 Feb;17(1):63-8.
  • Kayacan SM, Türkmen A, Aliş H, Imer M, Barlas O, Ecder ST, Yildiz A, Aydin AE, Eldegez U, Sever MS. Successful therapy combined with surgery for severe post-transplant nocardiosis.J Nephrol. 2001 Jul-Aug;14(4):304-6.
  • Yelken BM, Gorgulu N, Caliskan Y, Yazici H, Turkmen A, Yildiz A, Sever MS.Comparison of nutritional status in hemodialysis patients with and without failed renal allografts. Clin Transplant. 2010 Jul-Aug;24(4):481-7.
  • Caliskan Y, Yelken B, Gorgulu N, Ozkok A, Yazici H, Telci A, Turkmen A, Yildiz A, Sever MS. Comparison of markers of appetite and inflammation between hemodialysis patients with and without failed renal transplants. J Ren Nutr. 2012;22(2):258-67.
  • Alpay N, Ozkok A, Caliskan Y, Akagun T, Cinar SA, Deniz G, Sariyar M, Yildiz A.Influence of conversion from calcineurin inhibitors to everolimus on fibrosis, inflammation, tubular damage and vascular function in renal transplant patients.Clin Exp Nephrol. 2014 Dec;18(6):961-7.
  • Gorgulu N, Yelken B, Caliskan Y, Elitok A, Cimen AO, Yazici H, Oflaz H, Golcuk E, Ekmekci A, Turkmen A, Yildiz A, Sever MS. Endothelial dysfunction in hemodialysis patients with failed renal transplants. Clin Transplant. 2010;24(5):678-84.
  • Caliskan Y, Yildiz A. Evaluation of the medically complex living kidney donor.J Transplant. 2012;2012:450471.
  • Akagun T, Caliskan Y, Yazici H, Ozkok A, Telci A, Turkmen A, Yildiz A, Sever MS.Elevated resistin levels are associated with inflammation in hemodialysis patients with failed renal allografts. Int J Artif Organs. 2014 May;37(5):358-63.
  • de Fijter JW, Holdaas H, Øyen O, et al. ; ELEVATE Study Group.Early Conversion From Calcineurin Inhibitor- to Everolimus-Based Therapy Following Kidney Transplantation: Results of the Randomized ELEVATE Trial.Am J Transplant. 2017 Jul;17(7):1853-1867.
  • Sever MS, Turkmen A, Sahin S, Yildiz A, Ecder T, Kayacan MS, Nane I, Aydin AE, Eldegez U. Renal transplantation in amyloidosis secondary to familial Mediterranean fever.Transplant Proc. 2001 Nov-Dec;33(7-8):3392-3.
  • Kazancioğlu R,Sever MS,Yüksel-Onel D, Eraksoy H, Yildiz A, Celik AV, Kayacan SM, Badur S. Immunization of renal transplant recipients with pneumococcal polysaccharide vaccine.Clin Transplant. 2000 Feb;14(1):61-5.
  • Caliskan Y, Oflaz H, Demirturk M, Yazici H, Turkmen A, Cimen A, Elitok A, Yildiz A.Coronary flow reserve dysfunction in hemodialysis and kidney transplant patients.Clin Transplant. 2008 Nov-Dec;22(6):785-93.
  • Caliskan Y, Yazici H, Gorgulu N, Yelken B, Emre T, Turkmen A, Yildiz A, Aysuna N, Bozfakioglu S, Sever MS. Effect of pre-transplant dialysis modality onkidney transplantation outcome. Perit Dial Int. 2009 Feb;29 Suppl 2:S117-22.
  • Yildiz A, Akkaya V, Kiliçaslan I, Türkmen A, Görçin B, Atilgan D, Sever MS.Cardiac and intestinal amyloidosis in a renal transplant recipient with familial Mediterranean fever. J Nephrol. 2001 Mar-Apr;14(2):125-7.
  • Türkmen A, Yildiz A, Erkoç R, Ecder T, Görçin B, Türk S, Aydin AE, Eldegez U, Ark E,Sever MS. Transplantation in renal amyloidosis. Clin Transplant. 1998 ;12(5):375-8.
  • Sever MS, Türkmen A, Yildiz A, Ecder T, Orhan Y. Fever in dialysis patients with recently rejected renal allografts. Int J Artif Organs. 1998 Jul;21(7):403-7.

Dr. Alaattin Yıldız’ın Kronik Böbrek Yetersizliği ile İlgili Uluslararası Yayınları

  • Ozkok A, Yildiz A. Hepatitis C virus associated glomerulopathies.World J Gastroenterol. 2014 ; 28;20(24):7544-54.
  • Ozkok A, Kekik C, Karahan GE, Sakaci T, Ozel A, Unsal A, Yildiz A.FGF-23 associated with the progression of coronary artery calcification in hemodialysis patients. BMC Nephrol. 2013 Nov 1;14:241.
  • Guney M, Ozkok A, Caliskan Y, Pusuroglu H, Yazici H, Tepe S, Oflaz H, Yildiz A.QT dispersion predicts mortality and correlates with both coronary artery calcification and atherosclerosis in hemodialysis patients. Int Urol Nephrol. 2014 Mar;46(3):599-605.
  • Ozkok A, Aktas E, Yilmaz A, Telci A, Oflaz H, Deniz G, Yildiz A.Decrease in progenitor cells associated with inflammation, but not with endothelial dysfunction in chronic hemodialysis patients. Clin Nephrol. 2013 Jan;79(1):21-30.
  • Caliskan Y, Yelken B, Ozkok A, Gorgulu N, Yazici H, Telci A, Yildiz A. Lower serum prohepcidin levels associated with lower iron and erythropoietin requirements in hemodialysis patients with chronic hepatitis C. BMC Nephrol. 2012 Jul 7;13:56.
  • Ozkok A, Caliskan Y, Sakaci T, Erten G, Karahan G, Ozel A, Unsal A, Yildiz A.Osteoprotegerin/RANKL axis and progression of coronary artery calcification in hemodialysis patients. Clin J Am Soc Nephrol. 2012 Jun;7(6):965-73.
  • Yelken B, Caliskan Y, Gorgulu N, Altun I, Yilmaz A, Yazici H, Oflaz H, Yildiz A.Reduction of uric acid levels with allopurinol treatment improves endothelial function in patients with chronic kidney disease. Clin Nephrol. 2012 Apr;77(4):275-82.
  • Turkmen K, Gorgulu N, Uysal M, Ozkok A, Sakaci T, Unsal A, Yildiz A.Fetuin-A, inflammation, and coronary artery calcification in hemodialysis patients.Indian J Nephrol. 2011 Apr;21(2):90-4.
  • Yazici H, Oflaz H, Pusuroglu H, Tepe S, Dogan C, Basci A, Akkaya V, Yildiz A.Hypervolemia rather than arterial calcification and extracoronary atherosclerosis is the main determinant of pulse pressure in hemodialysis patients.Int Urol Nephrol. 2012 Aug;44(4):1203-10.
  • Koc M, Dogan C, Arinsoy T, Tonbul Z, Ayli D, Cirit M, Sever MS, Yilmaz ME, Unsal A, Suleymanlar G, Ok E, Basci A, Yildiz A. Statin use is associated with lower inflammation and erythropoietin responsiveness index in hemodialysispatients.Hemodial Int. 2011 Jul;15(3):366-73.
  • Caliskan Y, Demirturk M, Ozkok A, Yelken B, Sakaci T, Oflaz H, Unsal A, Yildiz A.Coronary artery calcification and coronary flow velocity in haemodialysis patients.Nephrol Dial Transplant. 2010 Aug;25(8):2685-90.
  • Ozturk S, Soyluk O, Karakaya D, Yazici H, Caliskan YK, Yildiz A, Bozfakioglu S.Is decline in serum albumin an ominous sign for subsequent peritonitis in peritoneal dialysis patients? Adv Perit Dial. 2009;25:172-7.
  • Bayraktar G, Kurtulus I, Kazancioglu R, Bayramgurler I, Cintan S, Bural C, Bozfakioglu S, Issever H, Yildiz A. Oral health and inflammation in patients with end-stage renal failure.Perit Dial Int. 2009 Jul-Aug;29(4):472-9.
  • Caliskan Y, Oflaz H, Pusuroglu H, Boz H, Yazici H, Tamer S, Karsidag K, Yildiz A.Hepatitis C virus infection in hemodialysis patients is not associated with insulin resistance, inflammation and atherosclerosis. Clin Nephrol. 2009 Feb;71(2):147-57.
  • Bayraktar G, Kurtulus I, Kazancioglu R, Bayramgurler I, Cintan S, Bural C, Besler M,Trablus S, Issever H, Aysuna N, Ozkan O, Yildiz A.  Effect of educational level on oral health in peritoneal and hemodialysis patients. Int J Dent. 2009:159767.
  • Ozturk S, Kocabay G, Topcular B, Yazici H, Cagatay AA, Bahat G, Baykan B, Turkmen A, Yildiz A. Non-convulsive status epilepticus following antibiotic therapy as a cause of unexplained loss of consciousness in patients with renal failure. Clin Exp Nephrol. 2009 Apr;13(2):138-144.
  • Ozturk S, Taymez DG, Bahat G, Demirel R, Yazici H, Aysuna N, Sakar S, Yildiz A.The influence of low dialysate sodium and glucose concentration on volüme distributions in body compartments after haemodialysis: a bioimpedance analysis study.Nephrol Dial Transplant. 2008 Nov;23(11):3629-34.
  • Bayraktar G, Kurtulus I, Kazancioglu R, Bayramgurler I, Cintan S, Bural C, Bozfakioglu S, Besler M, Trablus S, Issever H, Yildiz A. Evaluation of periodontal parameters in patients undergoing peritoneal dialysis or hemodialysis. Oral Dis. 2008 Mar;14(2):185-9.
  • Ozturk S, Arpaci D, Yazici H, Taymez DG, Aysuna N, Yildiz A, Sever MS.Outcomes of acute renal failure patients requiring intermittent hemodialysis.Ren Fail. 2007;29(8):991-6.
  • Bayraktar G, Kurtulus I, Duraduryan A, Cintan S, Kazancioglu R, Yildiz A, Bural C, Bozfakioglu S, Besler M, Trablus S, Issever H. Dental and periodontal findings in hemodialysis patients. Oral Dis. 2007 Jul;13(4):393-7.
  • Tonbul HZ, Demir M, Altintepe L, Güney I, Yeter E, Türk S, Yeksan M, Yildiz A.Malnutrition-inflammation-atherosclerosis (MIA) syndrome components in hemodialysis and peritoneal dialysis patients. Ren Fail. 2006;28(4):287-94.
  • Can M, Demirtaş S, Polat O, Yildiz A. Is cystatin C a reliable renal marker in trauma?Clin Chem Lab Med. 2006;44(4):510-1.
  • Turk S, Atalay H, Altintepe L, Güney I, Okudan N, Tonbul HZ, Gökbel H, Kücür R, Yeksan M, Yildiz A. Treatment with antidepressive drugs improved quality of life in chronic hemodialysis patients. Clin Nephrol. 2006 Feb;65(2):113-8.
  • Yildiz A, Memisoglu E, Oflaz H, Yazici H, Pusuroglu H, Akkaya V, Erzengin F, Tepe S. Atherosclerosis and vascular calcification are independent predictors of left ventricular hypertrophy in chronic haemodialysis patients. Nephrol Dial Transplant. 2005 Apr;20(4):760-7. Epub 2005 Feb 16.
  • Bayraktar G, Kazancioglu R, Bozfakioglu S, Yildiz A, Ark E. Evaluation of salivary parameters and dental status in adult hemodialysis patients. Clin Nephrol. 2004 Nov;62(5):380-3.
  • Altintepe L, Kurtoglu E, Tonbul Z, Yeksan M, Yildiz A, Türk S. Lower erythropoietin and iron supplementation are required in hemodialysis patients with hepatitis C virus infection.Clin Nephrol. 2004 May;61(5):347-51.
  • Yildiz A, Tepe S, Oflaz H, Yazici H, Pusuroglu H, Besler M, Ark E, Erzengin F. Carotid atherosclerosis is a predictor of coronary calcification in chronic haemodialysis patients. Nephrol Dial Transplant. 2004 Apr;19(4):885-91.
  • Türk S, Guney I, Altintepe L, Tonbul Z, Yildiz A, Yeksan M. Quality of life in male hemodialysis patients. Role of erectile dysfunction. Nephron Clin Pract. 2004;96(1):c21-7.
  • Alsancak S, Aydin M, Yildiz A, Salman S, Seçkin S. No association between oxidative stress and IL-6 in NIDDM patients with nephropathy. Folia Biol (Praha). 2003;49(6):235-7.
  • Gökkuşu CA,Ozden TA,Gül H, Yildiz A. Relationship between plasma Cystatin C and creatinine in chronic renal diseases and Tx-transplant patients. Clin Biochem. 2004 Feb;37(2):94-7.
  • Voziyan PA, Khalifah RG, Thibaudeau C, Yildiz A, Jacob J, Serianni AS, Hudson BG. Modification of proteins in vitro by physiological levels of glucose: pyridoxamine inhibits conversion of Amadori intermediate to advanced glycation end-products through binding of redox metal ions. J Biol Chem. 2003 Nov 21;278(47):46616-24. Epub 2003 Sep 15.
  • Yildiz A, Ikizler A. [Prevention of radiocontrast nephropathy].Anadolu Kardiyol Derg. 2003 Jun;3(2):104-6. Turkish.
  • Tonbul Z, Altintepe L, Sözlü C, Yeksan M, Yildiz A, Türk S. The association of peritoneal transport properties with 24-hour blood pressure levels in CAPD patients.Perit Dial Int. 2003 Jan-Feb;23(1):46-52.
  • Yildiz A, Oflaz H, Pusuroglu H, Mercanoglu F, Genchallac H, Akkaya V, Ikizler TA, Sever MS. Left ventricular hypertrophy and endothelial dysfunction in chronic hemodialysis patients.Am J Kidney Dis. 2003 Mar;41(3):616-23.
  • Yildiz A, Hursit M, Celik AV, Kayacan SM, Yazici H, Akkaya V, Gürol AO, Karsidag K. Doxazosin, but not amlodipine decreases insulin resistance in patients with chronic renal failure: a prospective, randomized-controlled study. Clin Nephrol. 2002 Dec;58(6):405-10.
  • Tonbul Z, Altintepe L, Sözlü C, Yeksan M, Yildiz A, Türk S. Ambulatory blood pressure monitoring in haemodialysis and continuous ambulatory peritoneal dialysis (CAPD) patients.J Hum Hypertens. 2002 Aug;16(8):585-9.
  • Cefle K, Yildiz A, Palanduz S, Ozturk S, Ozbey N, Kylyçaslan I, Colakoglu S, Balci C.Chronic renal failure in a patient with Sotos syndrome due to autosomal dominant polycystic kidney disease. Int J Clin Pract. 2002 May;56(4):316-8.
  • Bayraktar G, Kazancioglu R, Bozfakioglu S, Ecder T, Yildiz A, Ark E. Stimulated salivary flow rate in chronic hemodialysis patients. Nephron. 2002 Jun;91(2):210-4.
  • Galliano M, Campagnoli M, Rossi A, Wirsing von König CH, Lyon AW, Cefle K, Yildiz A, Palanduz S, Ozturk S, Minchiotti L. Molecular diagnosis of analbuminemia: a novel mutation identified in two Amerindian and two Turkish families. Clin Chem. 2002 Jun;48(6 Pt 1):844-9.
  • Türk S, Akbulut M, Yildiz A, Gürbilek M, Gönen S, Tombul Z, Yeksan M. Comparative effect of oral pulse and intravenous calcitriol treatment in hemodialysis patients: the effect on serum IL-1 and IL-6 levels and bone mineral density. Nephron. 2002 Feb;90(2):188-94.
  •  Türk S, Karalezli G, Tonbul HZ, Yildiz M, Altintepe L, Yildiz A, Yeksan M.Erectile dysfunction and the effects of sildenafil treatment in patients on haemodialysis and continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant. 2001 Sep;16(9):1818-22.
  • Yildiz A, Akkaya V, Sahin S, Tükek T, Besler M, Bozfakioglu S, Korkut F. QT dispersion and signal-averaged electrocardiogram in hemodialysis and CAPD patients.Perit Dial Int. 2001 Mar-Apr;21(2):186-92.
  • Kazancioğlu R, Korular D, Sever MS, Türkmen A, Aysuna N, Kayacan SM, Tahin S, Yildiz A, Bozfakioğlu S, Ark E. The outcome of patients presenting with crush syndrome after the Marmara earthquake. Int J Artif Organs. 2001 Jan;24(1):17-21.
  • Yildiz A, Akkaya V, Hatemi AC, Cine N, Tükek T, Görçin B, Demirel S, Türk S, Sever MS.No association between deletion-type angiotensin-converting enzyme gene polymorphism and left-ventricular hypertrophy in hemodialysis patients. Nephron. 2000 Feb;84(2):130-5.
  • Yildiz A, Akkaya V, Yildiz P, Tûrk S, Görel N, Sever MS, Badur S. No relation of tuberculin reactivity with quantitative analysis of peripheral blood lymphocyte subsets in haemodialysis patients. Respir Med. 1999 Feb;93(2):119-22.
  • Yildiz A, Akkaya V, Türk S, Sever MS, Ark E, Yildiz P. Tuberculin responsiveness in hemodialysis patients. Chest. 1998 Sep;114(3):947-8.
  • Yildiz A, Akkaya V, Sever MS, Bozfakioglu S, Kudat H, Demirel S, Ark E. Heart rate variability in patients with secondary amyloidosis. Isr J Med Sci. 1997Dec;33(12):781-5.
  • Türkmen A, Sever MS, Ecder T, Yildiz A, Aydin AE, Erkoç R, Eraksoy H, Eldegez U, Ark E. Posttransplant malaria. Transplantation. 1996 Nov 27;62(10):1521-3.
  • Sever MS, Türkmen A, Yildiz A, Ecder T. Successful treatment of Kaposi's sarcoma in a renal allograft recipient. Nephrol Dial Transplant. 1996 Jan;11(1):223.
  • Erdan A, Ozkok A, Alpay N, Akkaya V, Yildiz A.Volume status and arterial blood pressures are associated with arterial stiffness in hemodialysis patients.Int J Artif Organs. 2018 Jul;41(7):378-384.
  • Ozkok A, Yildiz A. Endothelial Progenitor Cells and Kidney Diseases.Kidney Blood Press Res. 2018;43(3):701-718.
  • Ozkok A, Atas R, Cinar SA, Yilmaz A, Aktas E, Deniz G, Yildiz A.CD133+ cells are associated with ADIPOCYTOKINES and endothelial dysfunction in hemodialysis patients. BMC Nephrol. 2017 Jul 26;18(1):250.
  •  Aliyeva N, Demir E, Caliskan Y, Yazici H, Yildiz A. A Rare Clinical Entity:
  • Staphylococcus-Related Glomerulonephritis. Exp Clin Transplant. 2017 Mar 28. doi:10.6002/ect.2016.0066.
  • Üstündağ S, Doğan E, Duranay M, Kazancıoğlu R, Çelik V, Ünsal A, Altıntepe L, Dursun B,Akbaş E, Özdener F, Yıldız A. Subcutaneous C.E.R.A. for the Treatment of Chronic Renal Anemia in Predialysis Patients. Balkan Med J. 2016 May;33(3):322-30.
  • Duman N, Uyanik A, Unsal A, Sezer S, Camsari T, Cirit M, Yilmaz ME, Altun B, Duranay M, Yildiz A, Sahin I, Dogukan A, Ustundag S, Karayaylali I, Kahveci A, Sindel S, Kiykim AA, Yenicerioglu Y, Akbas E, Ozdener F. Once-monthly continuous  erythropoietin receptor activator (CERA) for haemoglobin maintenance in haemodialysis patients with chronic renal anaemia. Clin Kidney J. 2014 Oct;7(5):464-9.